Advertorial, Bayer. “Advertorial: EMA REAFFIRMS POSITIVE BENEFIT-RISK BALANCE OF BAYER’S XARELTO® FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION”. SA Heart Journal 13, no. 1 (March 20, 2017): 42–43. Accessed October 8, 2025. https://www.journals.ac.za/SAHJ/article/view/1694.